Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Romosozumab> ?p ?o }
Showing triples 1 to 64 of
64
with 100 triples per page.
- Romosozumab abstract "Romosozumab (AMG 785) is a humanized monoclonal antibody that targets sclerostin for the treatment of osteoporosis.Romosozumab was originally discovered by Celltech (now owned by UCB). Celltech entered in a partnership with Amgen in 2002 for the product's development.Romosozumab is of interest because of sclerostin's specificity to bone. Its use has increased bone growth in preclinical trials in osteoporotic rats and monkeys. In a Phase I study, a single dose of Romosozumab increased bone density in the hip and spine in healthy men and postmenopausal women and the drug was well tolerated. In a Phase II trial, one year of Romosozumab treatment in osteoporotic women increased bone density more than bisphosphonate and teriparatide treatment; it had mild injection side effects.As of January 2014, Phase 3 clinical trials are recruiting patients.".
- Romosozumab atcPrefix "none".
- Romosozumab casNumber "909395-70-6".
- Romosozumab wikiPageID "33024117".
- Romosozumab wikiPageLength "6410".
- Romosozumab wikiPageOutDegree "13".
- Romosozumab wikiPageRevisionID "707386192".
- Romosozumab wikiPageWikiLink Amgen.
- Romosozumab wikiPageWikiLink Bisphosphonate.
- Romosozumab wikiPageWikiLink Category:Amgen.
- Romosozumab wikiPageWikiLink Celltech.
- Romosozumab wikiPageWikiLink Humanized_antibody.
- Romosozumab wikiPageWikiLink Osteoporosis.
- Romosozumab wikiPageWikiLink Phases_of_clinical_research.
- Romosozumab wikiPageWikiLink Sclerostin.
- Romosozumab wikiPageWikiLink Teriparatide.
- Romosozumab wikiPageWikiLink UCB_(company).
- Romosozumab wikiPageWikiLinkText "Romosozumab".
- Romosozumab atcPrefix "none".
- Romosozumab c "6452".
- Romosozumab casNumber "909395".
- Romosozumab chemspiderid "none".
- Romosozumab h "9926".
- Romosozumab kegg "D10156".
- Romosozumab legalStatus "Investigational".
- Romosozumab mabType "mab".
- Romosozumab molecularWeight "145.9".
- Romosozumab n "1714".
- Romosozumab o "2040".
- Romosozumab s "54".
- Romosozumab source "zu/o".
- Romosozumab target Sclerostin.
- Romosozumab type "mab".
- Romosozumab verifiedfields "changed".
- Romosozumab verifiedrevid "464383486".
- Romosozumab wikiPageUsesTemplate Template:As_of.
- Romosozumab wikiPageUsesTemplate Template:Cascite.
- Romosozumab wikiPageUsesTemplate Template:Chemspidercite.
- Romosozumab wikiPageUsesTemplate Template:Drugbankcite.
- Romosozumab wikiPageUsesTemplate Template:Drugbox.
- Romosozumab wikiPageUsesTemplate Template:Keggcite.
- Romosozumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Romosozumab wikiPageUsesTemplate Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems.
- Romosozumab wikiPageUsesTemplate Template:Musculoskeletal-drug-stub.
- Romosozumab wikiPageUsesTemplate Template:Reflist.
- Romosozumab subject Category:Amgen.
- Romosozumab hypernym Antibody.
- Romosozumab type ChemicalSubstance.
- Romosozumab type Company.
- Romosozumab type Drug.
- Romosozumab type Antibody.
- Romosozumab type Chemical.
- Romosozumab type Company.
- Romosozumab type Drug.
- Romosozumab type ChemicalObject.
- Romosozumab type Thing.
- Romosozumab type Q8386.
- Romosozumab comment "Romosozumab (AMG 785) is a humanized monoclonal antibody that targets sclerostin for the treatment of osteoporosis.Romosozumab was originally discovered by Celltech (now owned by UCB). Celltech entered in a partnership with Amgen in 2002 for the product's development.Romosozumab is of interest because of sclerostin's specificity to bone. Its use has increased bone growth in preclinical trials in osteoporotic rats and monkeys.".
- Romosozumab label "Romosozumab".
- Romosozumab sameAs Q7363297.
- Romosozumab sameAs m.0h544ld.
- Romosozumab sameAs Q7363297.
- Romosozumab wasDerivedFrom Romosozumab?oldid=707386192.
- Romosozumab isPrimaryTopicOf Romosozumab.